AAAAAA

   
Results: 1-4 |
Results: 4
The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration
Authors: Reed, MD Rodarte, A Blumer, JL Khoo, KC Akbari, B Pou, S Kearns, GL
Citation: Md. Reed et al., The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration, J CLIN PHAR, 41(12), 2001, pp. 1359-1369
Eradication of Helicobacter pylori is associated with increased exposure to delavirdine in hypochlorhydric HIV-positive patients
Authors: Shelton, MJ Akbari, B Hewitt, RG Adams, JM Morse, GD
Citation: Mj. Shelton et al., Eradication of Helicobacter pylori is associated with increased exposure to delavirdine in hypochlorhydric HIV-positive patients, J ACQ IMM D, 24(1), 2000, pp. 79-82
Pediatric pharmacodynamics of midazolam oral syrup
Authors: Marshall, J Rodarte, A Blumer, J Khoo, KC Akbari, B Kearns, G
Citation: J. Marshall et al., Pediatric pharmacodynamics of midazolam oral syrup, J CLIN PHAR, 40(6), 2000, pp. 578-589
Effect of orlistat, a novel anti-obesity agent, on the pharmacokinetics and pharmacodynamics of pravastatin in patients with mild hypercholesterolaemia
Authors: Oo, CY Akbari, B Lee, S Nichols, G Hellmann, CP
Citation: Cy. Oo et al., Effect of orlistat, a novel anti-obesity agent, on the pharmacokinetics and pharmacodynamics of pravastatin in patients with mild hypercholesterolaemia, CLIN DRUG I, 17(3), 1999, pp. 217-223
Risultati: 1-4 |